We are a venture-backed company located in Laguna Hills, California developing novel radiofrequency balloon catheter technology directed towards a variety of clinical applications including (i) the treatment of medication-resistant hypertension via percutaneous renal denervation and (ii) peripheral in-stent restenosis. Our newest product, the V2 Renal Denervation System for hypertension promises to greatly simplify the renal denervation procedure by employing a novel RF balloon catheter specifically designed for this clinical application. The Company began its mult-center international REDUCE-HTN clinical study for the treatment of hypertension in Q1 2012.  Vessix Vascular is ISO 13485 Compliant. Vessix products are not cleared for sale in the United States.